| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |